Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules

Erica Di Cesare1, Annalisa Verrico1, Andrea Miele1,2

  • 1Institute of Molecular Biology and Pathology, CNR National Research Council, c/o Department of Biology and Biotechnology, Sapienza Università di Roma, Roma, Italy.

Oncotarget
|February 5, 2017
PubMed

Insights

Arylthioindoles (ATIs) are novel tubulin polymerization inhibitors that arrest cancer cell division. These compounds display distinct efficacies and cellular fates, offering diverse therapeutic potential beyond current tubulin-targeting agents.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Tubulin-targeting agents are crucial in cancer therapy, inhibiting cell division by disrupting microtubule structures.
  • The cellular response to tubulin polymerization inhibitors is less understood compared to microtubule dynamics inhibitors.
  • Arylthioindoles (ATIs) are a novel class of tubulin inhibitors with demonstrated anti-cancer activity.

Purpose of the Study:

  • To comprehensively characterize the cellular response of cancer cell lines to five selected arylthioindoles (ATIs).
  • To investigate the differential efficacy and cell fate outcomes induced by ATIs with similar in vitro polymerization inhibitory activity.
  • To elucidate the molecular mechanisms underlying ATI-induced cell death, including mitotic apparatus damage, MCL-1 down-regulation, and caspase-3 activation.

Main Methods:

  • In vitro tubulin polymerization assays.
  • Cancer cell line viability assays.
  • Time-lapse microscopy for cell fate profiling.
  • Cytological analysis of mitotic apparatus.
  • Western blotting for MCL-1 and caspase-3 activation.

Main Results:

  • All tested ATIs effectively inhibited tubulin polymerization and arrested mitotic progression in cancer cells.
  • Distinct cell fate profiles were observed among ATIs, despite similar in vitro activity, highlighting differential in vivo efficacy.
  • ATIs induced varying degrees of mitotic apparatus damage, correlating with MCL-1 down-regulation and caspase-3 activation, determining cell death.
  • The study identified specific ATIs with distinct cytological phenotypes and downstream signaling events.

Conclusions:

  • Arylthioindoles exhibit diverse cellular responses and efficacies, offering a broader spectrum of tubulin-targeting cancer therapies.
  • Differential damage to the mitotic apparatus and subsequent apoptotic signaling pathways dictate the terminal cell fate.
  • These findings expand the understanding of tubulin inhibitor mechanisms and identify promising candidates for novel anti-cancer drug development.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
6.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K